254 related articles for article (PubMed ID: 28757310)
1. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
[TBL] [Abstract][Full Text] [Related]
2. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.
Tsuji R; Crofton KM
Congenit Anom (Kyoto); 2012 Sep; 52(3):122-8. PubMed ID: 22925212
[TBL] [Abstract][Full Text] [Related]
3. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
[TBL] [Abstract][Full Text] [Related]
4. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
[TBL] [Abstract][Full Text] [Related]
5. Assessment of learning, memory and attention in developmental neurotoxicity regulatory studies: Introduction.
Makris SL; Vorhees CV
Neurotoxicol Teratol; 2015; 52(Pt A):62-7. PubMed ID: 26049062
[TBL] [Abstract][Full Text] [Related]
6. Developmental neurotoxicity testing: scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011.
Aoyama H
Congenit Anom (Kyoto); 2012 Sep; 52(3):119-21. PubMed ID: 22925211
[TBL] [Abstract][Full Text] [Related]
7. Current Topics in Postnatal Behavioral Testing.
Henck JW; Elayan I; Vorhees C; Fisher JE; Morford LL
Int J Toxicol; 2016 Sep; 35(5):499-520. PubMed ID: 27381384
[TBL] [Abstract][Full Text] [Related]
8. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426.
Makris SL; Raffaele K; Allen S; Bowers WJ; Hass U; Alleva E; Calamandrei G; Sheets L; Amcoff P; Delrue N; Crofton KM
Environ Health Perspect; 2009 Jan; 117(1):17-25. PubMed ID: 19165382
[TBL] [Abstract][Full Text] [Related]
9. The use of developmental neurotoxicity data in pesticide risk assessments.
Raffaele KC; Rowland J; May B; Makris SL; Schumacher K; Scarano LJ
Neurotoxicol Teratol; 2010; 32(5):563-72. PubMed ID: 20398750
[TBL] [Abstract][Full Text] [Related]
10. An expert-driven literature review of "negative" chemicals for developmental neurotoxicity (DNT) in vitro assay evaluation.
Martin MM; Baker NC; Boyes WK; Carstens KE; Culbreth ME; Gilbert ME; Harrill JA; Nyffeler J; Padilla S; Friedman KP; Shafer TJ
Neurotoxicol Teratol; 2022; 93():107117. PubMed ID: 35908584
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
[TBL] [Abstract][Full Text] [Related]
14. Assessment of learning, memory, and attention in developmental neurotoxicity regulatory studies: synthesis, commentary, and recommendations.
Vorhees CV; Makris SL
Neurotoxicol Teratol; 2015; 52(Pt A):109-15. PubMed ID: 26526903
[TBL] [Abstract][Full Text] [Related]
15. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
Vorhees CV; Sprowles JN; Regan SL; Williams MT
Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
[TBL] [Abstract][Full Text] [Related]
16. In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines.
Tyl RW
Birth Defects Res C Embryo Today; 2010 Jun; 90(2):99-102. PubMed ID: 20544693
[TBL] [Abstract][Full Text] [Related]
17. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
Sachana M; Willett C; Pistollato F; Bal-Price A
Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
[TBL] [Abstract][Full Text] [Related]
18. Continuing education course #3: current practices and future trends in neuropathology assessment for developmental neurotoxicity testing.
Bolon B; Garman RH; Gundersen HJ; Allan Johnson G; Kaufmann W; Krinke G; Little PB; Makris SL; Mellon RD; Sulik KK; Jensen K
Toxicol Pathol; 2011 Jan; 39(1):289-93. PubMed ID: 21075916
[TBL] [Abstract][Full Text] [Related]
19. Revolutionizing developmental neurotoxicity testing - a journey from animal models to advanced in vitro systems.
Smirnova L; Hogberg HT; Leist M; Hartung T
ALTEX; 2024; 41(2):152-178. PubMed ID: 38579692
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
